SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-137518
Filing Date
2020-05-08
Accepted
2020-05-08 16:00:33
Documents
4
Period of Report
2020-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927773d8k.htm 8-K 18791
2 EX-99.1 d927773dex991.htm EX-99.1 53562
3 EX-99.2 d927773dex992.htm EX-99.2 31963
4 GRAPHIC g927773g56c91.jpg GRAPHIC 2432
  Complete submission text file 0001193125-20-137518.txt   108916
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 20860420
SIC: 3841 Surgical & Medical Instruments & Apparatus